dr. naumann on unanswered questions with parp inhibitors in ovarian cancer
Published 4 years ago • 149 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
1:19
dr. naumann on improving outcomes with chemotherapy in ovarian cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
0:46
dr. chase on toxicities with niraparib in ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
1:22
dr. naumann on data with stro-002 in platinum-resistant/refractory ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
1:06
dr. backes discusses her experience with parp inhibitors in ovarian cancer
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
0:45
dr. coffman on safety concerns with parp inhibitors in ovarian cancer
-
1:48
dr. westin on advances made with parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
2:03
dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
1:07
dr. westin on emerging parp inhibitors in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer